CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Finance Lease, Liability, to be Paid, Year Five
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Finance Lease, Liability, to be Paid, Year Five of $3.14 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive · last filed 2026-02-18
- 2025-12-27: Finance Lease, Liability, to be Paid, Year Five $3.14M.
- 2024-12-28: Finance Lease, Liability, to be Paid, Year Five $3.03M.
- 2023-12-30: Finance Lease, Liability, to be Paid, Year Five $2.99M.
- 2022-12-31: Finance Lease, Liability, to be Paid, Year Five $2.92M.
| Period end | Finance Lease, Liability, to be Paid, Year Five |
|---|---|
| 2025-12-27 | $3.14M 10-K · filed 2026-02-18 |
| 2024-12-28 | $3.03M 10-K · filed 2025-02-19 |
| 2023-12-30 | $2.99M 10-K · filed 2024-02-14 |
| 2022-12-31 | $2.92M 10-K · filed 2023-02-22 |
| 2021-12-25 | $2.46M 10-K · filed 2022-02-16 |
| 2020-12-26 | $2.84M 10-K · filed 2021-02-17 |
| 2020-03-28 | $2.15M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $2.14M 10-K · filed 2020-02-11 |
| 2019-09-28 | $2.76M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $2.86M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $2.27M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |